Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV

NCT02690103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: pegylated IFN
DIETARY_SUPPLEMENT: Biobran
DRUG: Ribavirin

Sponsor

Cairo University

Collaborators

[object Object]
[object Object]